US Supreme Court weighs key standard in whistleblower fraud cases
By John Kruzel WASHINGTON (Reuters) -The U.S. Supreme Court on Tuesday considered a bid by three whistleblowers to revive lawsuits accusing pharmacy operators of pocketing millions of taxpayer dollars by knowingly overbilling government health insurance programs for prescription drugs. The justices heard arguments in an appeal by the whistleblowers of lower court rulings in favor…
